Cy5 NHS ester(Et): Protein Labeling Guide
2026-09-07
Cy5 NHS ester(Et) is a water-soluble, amine-reactive fluorescent reagent for covalent labeling of proteins, peptides, and other biomolecules. It is suitable for immunofluorescence staining, flow cytometry, and fluorescence microscopy, but should not be selected for ethanol-based dissolution or long-term storage of prepared dye solutions.
EPI-001: AR N-Terminal Domain Inhibitor Workflows
2026-09-05
EPI-001 enables researchers to interrogate androgen receptor transcriptional activity beyond ligand-binding-domain biology, with practical value in prostate cancer, CRPC, and exploratory ARv7 studies. This guide combines solvent handling, response profiling, migration assays, and troubleshooting strategies for more reproducible mechanistic experiments.
rTMS, GABAergic Neurons, and Amyloid Clearance in AD
2026-09-05
This 2025 Cell Proliferation study links repetitive transcranial magnetic stimulation to cognitive recovery in 5xFAD mice through GABAergic neuron activation and enhanced Cx3cl1–Cx3cr1 signaling. Its integrated transcriptomic, cellular, pathological, and behavioral framework suggests that neuromodulation may improve microglial amyloid clearance while reducing neuroinflammation, although the mechanism and translational value require further validation.
BRD4 Inhibition Potentiates Erastin-Induced Ferroptosis
2026-09-04
The 2024 Discover Oncology study shows that pharmacological or genetic BRD4 inhibition sensitizes several cell lines to erastin-induced ferroptosis. Its key mechanistic contribution is linking this sensitization to reactive oxygen species accumulation and reduced FSP1 expression, supporting combination strategies in cancer biology research.
2'3'-cGAMP: Practical STING Assay Workflows
2026-09-04
Use 2'3'-cGAMP as a high-affinity STING pathway activator, a positive control for interferon assays, and a mechanistic probe that separates STING competence from upstream cGAS or mitochondrial DNA-release defects. This workflow connects chronic NAD-depletion research with reproducible innate immune experiments while emphasizing aqueous handling, time-resolved readouts, and troubleshooting.
G4–STAT1 Disruption Enhances Olaparib Cancer Killing
2026-09-03
A 2026 Nucleic Acids Research study identifies a parallel G-quadruplex in the BLM promoter as a regulatory platform that recruits phosphorylated STAT1 and promotes BLM expression. Berberine and coptisine disrupt this interaction and synergize with Olaparib, linking promoter G4 biology to DNA damage response failure and a potential combination strategy for cancer research.
NAD+: Redox Control of Autophagy Assays
2026-09-03
Explore how Nicotinamide Adenine Dinucleotide (NAD+) connects redox chemistry, signaling, and autophagy interpretation. This guide translates a revised AMPK–ULK1 model into better metabolic-stress assay design and NAD+ handling decisions.
Regorafenib: From Kinase Panel to Phenotype
2026-09-02
Regorafenib (BAY 73-4506) is more than a broad kinase inhibitor: it is a powerful tool for connecting angiogenic signaling to tumor-cell phenotypes. This guide translates kinase potency, RRM2 biology, and assay design into a practical framework for cancer biology research.
Regorafenib Suppresses Melanoma Through RRM2
2026-09-02
The 2024 iScience study identifies RRM2 as a downstream effector of Regorafenib in melanoma and connects its reduction to ERK/E2F3 signaling, apoptosis, and reduced malignant behavior. The findings provide a mechanistic framework for interpreting multikinase-inhibitor responses in melanoma models while highlighting important limits for translation beyond the tested systems.
Mc-Val-Cit-PABC-PNP: Practical ADC Workflow
2026-09-01
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows that evaluate payload release after lysosomal processing. Its high DMSO solubility and insolubility in water and ethanol make solvent control essential; it is intended for scientific research only, not diagnostic, clinical, or medical use.
ARL4C, FLS Proliferation, and RA Progression
2026-08-31
The reference study combines single-cell and bulk transcriptomic analyses with cellular perturbation, co-culture, and collagen-induced arthritis experiments to position ARL4C as a regulator of aggressive fibroblast-like synoviocytes and macrophage polarization in rheumatoid arthritis. Its findings connect ARL4C with FLS cell-cycle progression, PI3K/AKT and MAPK signaling, synovial inflammation, and cartilage damage, while also suggesting a framework for orthogonal S-phase validation.
Sodium Oxamate: LDH-A Workflow Guide
2026-08-31
Use Sodium Oxamate to connect LDH-A activity, lactate output, and lactylation-linked phenotypes in cancer cell models. This practical guide covers aqueous formulation, dose-finding, TNBC assay design, controls, and troubleshooting for more interpretable cancer metabolism research.
Caspase-4 as a Translational Pyroptosis Readout
2026-08-30
Caspase-4 activity can connect intracellular LPS sensing with inflammasome signaling, gasdermin-mediated membrane damage, and translational cell-fate decisions. This thought-leadership guide explains how to position the Caspase-4 Colorimetric Assay Kit within organelle-targeted cancer research, including enzyme-instructed self-assembly, while defining the controls and limitations needed for credible interpretation.
Oleanolic Acid, FXR, and Cholestatic Liver Injury
2026-08-29
The reference study links oleanolic acid-induced cholestatic liver injury to impaired FXR-dependent bile acid efflux and disruption of hepatocyte tight junctions. By combining transporter-function assays, structural readouts, and pharmacological intervention, it provides a mechanistic framework for studying how altered bile acid handling contributes to liver toxicity.
PDHA1 Succinylation Links α-KGA to CCA Immune Escape
2026-08-29
The reference study identifies a metabolic–immune circuit in cholangiocarcinoma in which PDHA1 K83 succinylation increases alpha-ketoglutaric acid accumulation, activates macrophage OXGR1–MAPK signaling, and suppresses MHC-II antigen presentation. Its preclinical data further indicate that inhibiting this axis with CPI-613 can improve the response to gemcitabine and cisplatin, providing a mechanistic framework for studying chemotherapy resistance.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page